What is actually involved in taking an advanced therapy medicinal product (ATMP) from a brilliant idea in the lab to a successful product on the market? Is it similar to the development of a combination product? Or a monoclonal antibody? Just how difficult can it be? The level of activity surrounding ATMPs has been increasing, with some remarkable therapeutic opportunities currently being explored.